In-Licensing

Methapharm is seeking opportunities for the acquisition or in-licensing of specialty, niche or under-promoted products from other pharmaceutical companies.

In today's environment of company mergers and product divestment, certain products – particularly older products or those with very small market potential – may not have their intrinsic value fully recognized by their current sponsors. As a niche marketing company, Methapharm is in a position to leverage the significant operational efficiencies associated with a smaller company focused on the marketing and distribution of smaller products. To that end, we have developed a professional, highly-motivated, and technically-proficient sales organization and infrastructure. We are licensed to sell prescription drugs in all 50 US States as well as Canada. Moreover, our ability to focus allows us to expend more efforts at smaller groups of product stakeholders thus allowing us to be successful with challenging product propositions.

We are interested in obtaining commercial rights for marketed products in the U.S. or Canada and we are flexible in terms of the structure of any arrangement and terms of any licensing agreement. Typically, products will already have been approved for sale in the United States or Canada or where a product's safety and efficacy has already been established. However, Methapharm's Regulatory Group can assist our partner companies with product and device registrations with the U.S. FDA (Food and Drug Administration) and the Canadian TPD (Therapeutics Product Directorate) in order to bring products to market.